🎉 M&A multiples are live!
Check it out!

Cochlear Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cochlear and similar public comparables like Myomo, InfuSystem, and SmartVest.

Cochlear Overview

About Cochlear

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.


Founded

1983

HQ

Australia
Employees

5.3K+

Website

cochlear.com

Financials

LTM Revenue $1.5B

LTM EBITDA $392M

EV

$10.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Cochlear Financials

Cochlear has a last 12-month revenue of $1.5B and a last 12-month EBITDA of $392M.

In the most recent fiscal year, Cochlear achieved revenue of $1.4B and an EBITDA of $366M.

Cochlear expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Cochlear valuation multiples based on analyst estimates

Cochlear P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.2B $1.4B XXX XXX XXX
Gross Profit $782M $916M XXX XXX XXX
Gross Margin 64% 65% XXX XXX XXX
EBITDA $308M $366M XXX XXX XXX
EBITDA Margin 25% 26% XXX XXX XXX
Net Profit $183M $190M XXX XXX XXX
Net Margin 15% 13% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Cochlear Stock Performance

As of March 17, 2025, Cochlear's stock price is AUD 262 (or $166).

Cochlear has current market cap of AUD 17.2B (or $10.8B), and EV of AUD 17.0B (or $10.8B).

See Cochlear trading valuation data

Cochlear Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$10.8B $10.8B XXX XXX XXX XXX $3.90

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Cochlear Valuation Multiples

As of March 17, 2025, Cochlear has market cap of $10.8B and EV of $10.8B.

Cochlear's trades at 7.2x LTM EV/Revenue multiple, and 27.4x LTM EBITDA.

Analysts estimate Cochlear's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Cochlear and 10K+ public comps

Cochlear Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $10.8B XXX XXX XXX
EV/Revenue 7.3x XXX XXX XXX
EV/EBITDA 28.1x XXX XXX XXX
P/E 44.7x XXX XXX XXX
P/E/Growth 3.3x XXX XXX XXX
EV/FCF 52.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cochlear Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Cochlear Valuation Multiples

Cochlear's NTM/LTM revenue growth is 9%

Cochlear's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Cochlear's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Cochlear's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Cochlear and other 10K+ public comps

Cochlear Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 15% XXX XXX XXX XXX
EBITDA Margin 26% XXX XXX XXX XXX
EBITDA Growth 19% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 35% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 31% XXX XXX XXX XXX
G&A Expenses to Revenue 10% XXX XXX XXX XXX
R&D Expenses to Revenue 12% XXX XXX XXX XXX
Opex to Revenue 56% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Cochlear Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Cochlear M&A and Investment Activity

Cochlear acquired  XXX companies to date.

Last acquisition by Cochlear was  XXXXXXXX, XXXXX XXXXX XXXXXX . Cochlear acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Cochlear

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Cochlear

When was Cochlear founded? Cochlear was founded in 1983.
Where is Cochlear headquartered? Cochlear is headquartered in Australia.
How many employees does Cochlear have? As of today, Cochlear has 5.3K+ employees.
Who is the CEO of Cochlear? Cochlear's CEO is Mr. Dig Howitt.
Is Cochlear publicy listed? Yes, Cochlear is a public company listed on ASX.
What is the stock symbol of Cochlear? Cochlear trades under COH ticker.
When did Cochlear go public? Cochlear went public in 1995.
Who are competitors of Cochlear? Similar companies to Cochlear include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Cochlear? Cochlear's current market cap is $10.8B
What is the current revenue of Cochlear? Cochlear's last 12-month revenue is $1.5B.
What is the current EBITDA of Cochlear? Cochlear's last 12-month EBITDA is $392M.
What is the current EV/Revenue multiple of Cochlear? Current revenue multiple of Cochlear is 7.2x.
What is the current EV/EBITDA multiple of Cochlear? Current EBITDA multiple of Cochlear is 27.4x.
What is the current revenue growth of Cochlear? Cochlear revenue growth between 2023 and 2024 was 15%.
Is Cochlear profitable? Yes, Cochlear is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.